Ted Ross

Ted Ross, Ph.D., is the Global Director of Vaccine Development at Cleveland Clinic.12 In this role, he leads the development of novel vaccine platforms for various infectious diseases, including influenza, HIV, and COVID-19.13

Professional Background

Dr. Ross is a highly renowned scientist with expertise in virology, vaccines, immunology, and microbiology.1 Prior to joining Cleveland Clinic, he was the Georgia Research Alliance Eminent Scholar of Infectious Diseases and director of the Center for Vaccines and Immunology at the University of Georgia.2 He has also served as the director of Vaccines and Viral Immunity at the Vaccine and Gene Therapy Institute of Florida.2

Research Focus

Dr. Ross's research primarily focuses on:

1. Developing advanced and longer-lasting flu vaccines to protect against multiple strains of the virus12
2. Designing novel vaccine platforms for infectious diseases like influenza, HIV, and COVID-1913
3. Creating vaccines against cancer and respiratory viruses, including respiratory syncytial virus (RSV) and arboviruses such as Dengue, Zika, and Chikungunya2

Achievements and Roles

• Holds a leadership role in the National Institutes of Health's Collaborative Influenza Vaccine Innovation Centers (CIVIC) network12
• Collaborates with the INCENTIVE program in the European Union and India on universal influenza and COVID-19 vaccines12
• President of the International Society for Vaccines2
• Has published over 230 peer-reviewed papers and book chapters on infectious disease and vaccine development2
• Participates in vaccine working groups at the NIH, CDC, and WHO2

Dr. Ross is based at Cleveland Clinic's Florida Research and Innovation Center in Port St. Lucie, Florida, but also works closely with researchers across Cleveland Clinic, including the Global Center for Pathogen & Human Health Research.12